Science News | Depression in Covid-19 Survivors More Treatable: Study

www.latestly.com
4 min read
fairly difficult
Get latest articles and stories on Science at LatestLY. The findings of a pilot study has found that depressed patients, who suffered from COVID respond better to standard antidepressants than people who haven't had COVID.
Amsterdam [Netherlands], October 9 (ANI): The findings of a pilot study has found that depressed patients, who suffered from COVID respond better to standard antidepressants than people who haven't had COVID.

The findings of the study were published in the journal 'European Neuropsychopharmacology'.

Also Read | Tips to Look and Feel Your Best This Holiday Season.

Around 40 per cent of COVID sufferers report the development of depression within 6 months of infection. The inflammation caused by COVID is believed to be the main reason for the development of depression. Now new research has shown that around 90 per cent of patients who have suffered from COVID respond to SSRIs, significantly more than would be expected.

Lead researcher Mario Mazza MD, San Raffaele University, Milano said, "We know that COVID has led to an epidemic of mental health problems. Post-COVID depression is a serious issue, with around 40 per cent of COVID patients developing depression within 6 months of infection. But this study indicates that patients who have had COVID have a better chance of managing their depression than we thought."

Also Read | Reserve a Spot With BioLight To Invest in Cutting-Edge Red Light Therapy Technology.

The researchers, from Professor Francesco Benedetti's Laboratory of Psychiatry and Clinical Psychobiology at San Raffaele Hospital in Milano,…
ANI
Read full article